£22m innovation boost for London: backing for heart health start-ups and quantum technology
Mayor of London Sadiq Khan announced £22m for three projects at the opening of London Life Sciences Week. The projects have also attracted more than £98m in match funding.
The money comes from UKRI's Local Innovation Partnerships Fund, which invests up to £500m nationally. Of London's £30m allocation, £22m went to three projects on 15 November, with the rest to be allocated later. With pledged match funding, total investment exceeds £120m.
The three projects
A venture builder co-led by King's College London and BioInnovation Institute (£5m) aims to turn cardiometabolic research into new companies. PHIX London, led by UCLPartners (£5m), will help firms test technology for detecting high blood pressure and irregular heart rhythms in the Harley Street Health District. The London Quantum Cluster, founded by UCL, Imperial and King's (£12m), will help companies test quantum technologies in health, transport, finance and energy.
London's life sciences sector
City Hall says London has more than 2,700 life sciences companies supporting around 40,000 jobs. London & Partners' analysis of Dealroom data shows London life sciences firms have raised $3.2bn in venture capital so far in 2026 — 35% more than in all of 2025 and the most in Europe.
Health impact
City Hall says better management of high blood pressure could prevent more than 1,200 heart attacks, 1,800 strokes and almost 1,000 deaths in London, saving the NHS about £46m.
This article is general information, not legal or financial advice. Always check the latest rules on GOV.UK or with a regulated professional.
Sources
Contains public sector information licensed under the Open Government Licence v3.0.
